vs

Side-by-side financial comparison of HAEMONETICS CORP (HAE) and OPEN TEXT CORP (OTEX). Click either name above to swap in a different company.

HAEMONETICS CORP is the larger business by last-quarter revenue ($1.3B vs $1.3B, roughly 1.0× OPEN TEXT CORP). OPEN TEXT CORP runs the higher net margin — 13.5% vs 7.3%, a 6.2% gap on every dollar of revenue. On growth, HAEMONETICS CORP posted the faster year-over-year revenue change (4.8% vs 2.2%). OPEN TEXT CORP produced more free cash flow last quarter ($305.0M vs $209.9M). Over the past eight quarters, HAEMONETICS CORP's revenue compounded faster (99.2% CAGR vs -3.0%).

Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.

Open Text Corporation is a global software company that develops and sells information management software.

HAE vs OTEX — Head-to-Head

Bigger by revenue
HAE
HAE
1.0× larger
HAE
$1.3B
$1.3B
OTEX
Growing faster (revenue YoY)
HAE
HAE
+2.6% gap
HAE
4.8%
2.2%
OTEX
Higher net margin
OTEX
OTEX
6.2% more per $
OTEX
13.5%
7.3%
HAE
More free cash flow
OTEX
OTEX
$95.1M more FCF
OTEX
$305.0M
$209.9M
HAE
Faster 2-yr revenue CAGR
HAE
HAE
Annualised
HAE
99.2%
-3.0%
OTEX

Income Statement — Q4 FY2026 vs Q3 FY2026

Metric
HAE
HAE
OTEX
OTEX
Revenue
$1.3B
$1.3B
Net Profit
$97.3M
$172.7M
Gross Margin
14.9%
73.1%
Operating Margin
83.4%
15.7%
Net Margin
7.3%
13.5%
Revenue YoY
4.8%
2.2%
Net Profit YoY
-42.0%
EPS (diluted)
$0.70

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HAE
HAE
OTEX
OTEX
Q1 26
$1.3B
$1.3B
Q4 25
$339.0M
$1.3B
Q3 25
$327.3M
$1.3B
Q2 25
$321.4M
$1.3B
Q1 25
$330.6M
$1.3B
Q4 24
$348.5M
$1.3B
Q3 24
$345.5M
$1.3B
Q2 24
$336.2M
$1.4B
Net Profit
HAE
HAE
OTEX
OTEX
Q1 26
$97.3M
$172.7M
Q4 25
$44.7M
$168.1M
Q3 25
$38.7M
$146.6M
Q2 25
$34.0M
$28.8M
Q1 25
$58.0M
$92.8M
Q4 24
$37.5M
$229.9M
Q3 24
$33.8M
$84.4M
Q2 24
$38.4M
$248.2M
Gross Margin
HAE
HAE
OTEX
OTEX
Q1 26
14.9%
73.1%
Q4 25
59.7%
74.0%
Q3 25
59.5%
72.8%
Q2 25
59.8%
72.3%
Q1 25
58.4%
71.6%
Q4 24
55.5%
73.3%
Q3 24
54.2%
71.7%
Q2 24
52.0%
72.5%
Operating Margin
HAE
HAE
OTEX
OTEX
Q1 26
83.4%
15.7%
Q4 25
19.9%
22.0%
Q3 25
17.9%
21.0%
Q2 25
16.8%
13.9%
Q1 25
21.6%
16.7%
Q4 24
16.9%
22.2%
Q3 24
15.0%
16.3%
Q2 24
11.8%
14.2%
Net Margin
HAE
HAE
OTEX
OTEX
Q1 26
7.3%
13.5%
Q4 25
13.2%
12.7%
Q3 25
11.8%
11.4%
Q2 25
10.6%
2.2%
Q1 25
17.5%
7.4%
Q4 24
10.8%
17.2%
Q3 24
9.8%
6.6%
Q2 24
11.4%
18.2%
EPS (diluted)
HAE
HAE
OTEX
OTEX
Q1 26
$0.70
Q4 25
$0.95
$0.66
Q3 25
$0.81
$0.58
Q2 25
$0.70
$0.11
Q1 25
$1.17
$0.35
Q4 24
$0.74
$0.87
Q3 24
$0.66
$0.32
Q2 24
$0.74
$0.91

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HAE
HAE
OTEX
OTEX
Cash + ST InvestmentsLiquidity on hand
$245.4M
$1.3B
Total DebtLower is stronger
$1.2B
$6.2B
Stockholders' EquityBook value
$796.3M
$4.0B
Total Assets
$2.4B
$13.3B
Debt / EquityLower = less leverage
1.53×
1.57×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HAE
HAE
OTEX
OTEX
Q1 26
$245.4M
$1.3B
Q4 25
$363.4M
$1.3B
Q3 25
$296.4M
$1.1B
Q2 25
$292.9M
$1.2B
Q1 25
$306.8M
$1.3B
Q4 24
$320.8M
$1.1B
Q3 24
$299.3M
$1.0B
Q2 24
$344.4M
$1.3B
Total Debt
HAE
HAE
OTEX
OTEX
Q1 26
$1.2B
$6.2B
Q4 25
$1.2B
$6.4B
Q3 25
$1.2B
$6.4B
Q2 25
$1.2B
$6.4B
Q1 25
$1.2B
$6.4B
Q4 24
$6.4B
Q3 24
$6.4B
Q2 24
$6.4B
Stockholders' Equity
HAE
HAE
OTEX
OTEX
Q1 26
$796.3M
$4.0B
Q4 25
$911.5M
$4.0B
Q3 25
$849.2M
$4.0B
Q2 25
$882.3M
$3.9B
Q1 25
$820.8M
$4.1B
Q4 24
$906.9M
$4.2B
Q3 24
$878.9M
$4.1B
Q2 24
$905.4M
$4.2B
Total Assets
HAE
HAE
OTEX
OTEX
Q1 26
$2.4B
$13.3B
Q4 25
$2.5B
$13.6B
Q3 25
$2.4B
$13.5B
Q2 25
$2.5B
$13.8B
Q1 25
$2.5B
$13.8B
Q4 24
$2.5B
$13.7B
Q3 24
$2.5B
$13.8B
Q2 24
$2.5B
$14.2B
Debt / Equity
HAE
HAE
OTEX
OTEX
Q1 26
1.53×
1.57×
Q4 25
1.34×
1.58×
Q3 25
1.44×
1.61×
Q2 25
1.39×
1.62×
Q1 25
1.49×
1.55×
Q4 24
1.51×
Q3 24
1.55×
Q2 24
1.52×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HAE
HAE
OTEX
OTEX
Operating Cash FlowLast quarter
$293.2M
$354.6M
Free Cash FlowOCF − Capex
$209.9M
$305.0M
FCF MarginFCF / Revenue
15.7%
23.8%
Capex IntensityCapex / Revenue
2.5%
3.9%
Cash ConversionOCF / Net Profit
3.01×
2.05×
TTM Free Cash FlowTrailing 4 quarters
$417.1M
$809.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HAE
HAE
OTEX
OTEX
Q1 26
$293.2M
$354.6M
Q4 25
$93.6M
$318.7M
Q3 25
$111.3M
$147.8M
Q2 25
$17.4M
$158.2M
Q1 25
$116.6M
$402.2M
Q4 24
$43.8M
$348.0M
Q3 24
$48.8M
$-77.8M
Q2 24
$-27.4M
$185.2M
Free Cash Flow
HAE
HAE
OTEX
OTEX
Q1 26
$209.9M
$305.0M
Q4 25
$87.2M
$279.4M
Q3 25
$106.3M
$101.2M
Q2 25
$13.6M
$124.0M
Q1 25
$100.9M
$373.8M
Q4 24
$35.2M
$306.7M
Q3 24
$39.4M
$-117.1M
Q2 24
$-33.1M
$145.2M
FCF Margin
HAE
HAE
OTEX
OTEX
Q1 26
15.7%
23.8%
Q4 25
25.7%
21.1%
Q3 25
32.5%
7.9%
Q2 25
4.2%
9.5%
Q1 25
30.5%
29.8%
Q4 24
10.1%
23.0%
Q3 24
11.4%
-9.2%
Q2 24
-9.8%
10.7%
Capex Intensity
HAE
HAE
OTEX
OTEX
Q1 26
2.5%
3.9%
Q4 25
1.9%
3.0%
Q3 25
1.5%
3.6%
Q2 25
1.2%
2.6%
Q1 25
4.7%
2.3%
Q4 24
2.5%
3.1%
Q3 24
2.7%
3.1%
Q2 24
1.7%
2.9%
Cash Conversion
HAE
HAE
OTEX
OTEX
Q1 26
3.01×
2.05×
Q4 25
2.09×
1.90×
Q3 25
2.88×
1.01×
Q2 25
0.51×
5.49×
Q1 25
2.01×
4.33×
Q4 24
1.17×
1.51×
Q3 24
1.44×
-0.92×
Q2 24
-0.71×
0.75×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HAE
HAE

Segment breakdown not available.

OTEX
OTEX

Customer support$564.8M44%
Cloud services and subscriptions$492.9M38%
License$145.1M11%
Professional service and other$79.6M6%

Related Comparisons